Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2020 · 10-Q
Revenue$0.00$0.00— vs Q2 2019 Net Income-$568.80K-$568.80KN/M vs Q2 2019 EPS Diluted$0.00$0.00— vs Q2 2019 Operating Income-$470,329N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
ended Jun 30, 2020 · filed Jul 31, 2020 · 31 d after period end